Bushenjjianpixiaozheng Prescription Combination Chemotherapy Treatment Stomach Postoperative Patients

Objective:To explore the Bushenjianpixiaozheng (BSJPXZ) prescription in patients with operation chemotherapy process and quality of life of the cellular immune function. Methods:60 cases were randomly divided into pure chemotherapy group and combination chemotherapy groups. Compared with healthy group,and observe the NK cell activity and ratio of CD3+,CD4+,CD8 +,CD4+ / CD8+ ,and quality of life score (Karnofky score). Results:First,Compared with healthy controls,NK cell activity ,CD3+,CD4 + significantly reduced (P0.05),and CD8+ increased significantly (P 0.05),cause CD4 + / CD8+ ratio lower (P0.01). Second,the comparison group before and after treatment,the pure chemotherapy group after treatment,CD3+,NK cells activity reduced significantly (P0.05). Two groups after treatment with combination chemotherapy group,NK cell activity,CD8+ higher than pure chemotherapy group (P0.05),CD3+,CD4+,CD4+ / CD8+ is more obvious difference (P0.01).Third,before and after the treatment group,combination chemotherapy treatment group was obviously higher than the pure chemotherapy group has no obvious changes before and after treatment by Karnofky score (P0.05). Two groups after treatment with combination chemotherapy group,Karnofky score significantly higher than the pure chemotherapy group (P0.01). Conclusion:BSJPXZ prescriptioncan significantly improve the process of chemotherapy patients after operation in cellular immune function and quality of life.